Using molecular test results to help choose cancer therapies
Oncology Knowledge Rapid Alerts: Integrating biomarker-driven clinical decision support for therapy selection at point-of-care
This study is working to make cancer treatment better by creating a tool that helps doctors find the best therapies for patients based on their unique genetic test results, so they can get the most effective care possible.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10526824 on NIH RePORTER |
What this research studies
This research aims to enhance cancer treatment by integrating clinical decision support directly into electronic health records (EHRs). It focuses on developing an algorithm that matches patients' molecular test results with targeted therapy options, making it easier for oncologists to select the most effective treatments. By providing real-time alerts and information, this project seeks to keep healthcare providers updated on the latest advancements in precision cancer medicine. The ultimate goal is to improve patient outcomes through personalized therapy selection based on genetic information.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with non-small cell lung cancer (NSCLC) who have undergone molecular testing.
Not a fit: Patients without a diagnosis of cancer or those who have not undergone molecular testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients.
How similar studies have performed: Previous research has shown success in integrating clinical decision support systems in oncology, indicating a promising approach for this project.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Osterman, Travis J — Vanderbilt University Medical Center
- Study coordinator: Osterman, Travis J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.